RecallDepth
Class II Terminated

Difluprednate Ophthalmic Emulsion, 0.05%, 5 mL bottle, RX only, Manufactured by Cipla Ltd., India, Manufactured for: Cipla USA, Inc., NJ 07059, NDC 69097-341-35.

Company
Cipla
Recall Initiated
August 22, 2022
Posted
September 14, 2022
Recall Number
D-1499-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
117,844 bottles
Firm Location
Warren, NJ, United States

Reason for Recall

Lack of Assurance of Sterility: customer complaint for defective container where breakage of the protective cap exposes tip of eye drop which could compromise sterility.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: DEG1HC2, DEG2HC2, DEG3HC2, DEG4HC2, DEG5HC2, DEG6HC2, Exp 01/2023; DEG1IC2, DEG2IC2, DEG3IC2, DEG4IC2, Exp 02/2023; DEG1LC2, DEG2LC2, Exp 05/2023; DEG1BD2, DEG2BD2, DEG3BD2, Exp 07/2023

More recalls by Cipla

View all recalls by this company →

Other recent Class II Drug recalls